GLP-1 Market
LLY $1271.94 ▼ -0.9% NVO $39.29 ▼ -0.2% PFE $29.91 ▼ -0.7% VKTX $26.90 ▲ +0.7% KLRA $12.81 ▼ -0.6% GPCR $22.08 ▼ -3.5% RHHBY $59.12 ▲ +3.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
GLP-1 & Obesity Medicine

Find My Trial

Search obesity and metabolic clinical trials by health condition, treatment type, and location.

Not sure where to start? Choose a health condition, select oral or injectable, or search for a drug you're curious about.

About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Health conditions
Select conditions
Match
Route
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

More filters
Reset

Start your search

Choose one or more health conditions, a treatment preference, or search for a drug to see potentially relevant clinical trials.